FHTX
Foghorn Therapeutics Inc.
Key Financials
Revenue
$30.9M
↑ 36.8%
Net Income
$-74283000
↑ 14.2%
Total Assets
$198.1M
↓ 30.2%
EPS (Diluted)
$-1.18
↑ 25.3%
Operating Income
$-86389000
↑ 15.9%
Total Liabilities
$306.6M
↓ 7.0%
Shareholders' Equity
$-108500000.00
↓ 138.3%
Cash & Equivalents
$80.9M
↑ 45.8%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | FHTX |
| Company Name | Foghorn Therapeutics Inc. |
| CIK | 1822462 |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 617-586-3100 |